Search or choose
Find the right test or package.
The PD-L1 Dako 22C3 IHC PharmDx is a crucial tool in the field of oncology, specifically designed to detect the presence of PD-L1 protein in non-small cell lung cancer (NSCLC) tissue samples. This qualitative immunohistochemical assay utilizes Monoclonal Mouse...
The PD-L1 Dako 22C3 IHC PharmDx is a crucial tool in the field of oncology, specifically designed to detect the presence of PD-L1 protein in non-small cell lung cancer (NSCLC) tissue samples. This qualitative immunohistochemical assay utilizes Monocl...
The PD-L1 Dako 22C3 IHC PharmDx is a crucial tool in the field of oncology, specifically designed to detect the presence of PD-L1 protein in non-small cell lung cancer (NSCLC) tissue samples. This qualitative immunohistochemical assay utilizes Monoclonal Mouse Anti-PD-L1, Clone 22C3 antibodies and is optimized for use with formalin-fixed, paraffin-embedded (FFPE) tissue sections.
To assess PD-L1 protein expression, the Combined Positive Score (CPS) is calculated. CPS is determined by counting the number of PD-L1 s...
The PD-L1 Dako 22C3 IHC PharmDx is a crucial tool in the field of oncology, specifically designed to detect the presence of PD-L1 protein in non-small cell lung cancer (NSCLC) tissue samples. This qualitative immunohistochemical assay utilizes Monoclonal Mouse Anti-PD-L1, Clone 22C3 antibodies and is optimized for use with formalin-fixed, paraffin-embedded (FFPE) tissue sections.
To assess PD-L1 protein expression, the Combined Positive Score (CPS) is calculated. CPS is determined by counting the number of PD-L1 st...
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.